GL1X · GenesisL1 explorer

Research workbench

Crystal structure of TA0583, an archaeal actin homolog, complex with ADP

Analyse Crystal structure of TA0583, an archaeal actin homolog, complex with ADP in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FSN
Type
protein
Length
621 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hypothetical protein TA0583
UniProt
Q9HKL4
Ligands
ADP, MG
Pockets
6 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHypothetical protein TA0583protein31038% helix, 27% strandQ9HKL4
BHypothetical protein TA0583protein31135% helix, 24% strandQ9HKL4

Ligands and binding sites

  • ADP · Adenosine-5'-diphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.660.8047MG, ADP
23620.650.8053MG, ADP
3730.480.8324empty
4730.380.7822empty
5690.350.7718empty

Interfaces

1 interface between chains.

  • A–B · 148 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 modified (engineered).

Compared structures

  • 2FSN · Crystal structure of Ta0583, an archaeal actin homolog, complex with ADP · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9HKL4 · AlphaFold monomer V2.0 prediction for archaeal actin homolog (Q9HKL4) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.